MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RNAZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TransCode Therapeutics (RNAZ) Ownership - Who owns TransCode Therapeutics?

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
12
Web
https://www.transcodetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.97M
P/E Ratio
0.00
Total Cash
8.38M
Projected Growth
N/A
Total Debt
652.41K
Revenue
N/A
Risk (Beta)
3.91
Dividend Yield
N/A
Total Cash/Share
0.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
RNAZ
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for RNAZ
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
12
Web
https://www.transcodetherapeutics.com
Who owns TransCode Therapeutics? RNAZ symbol Ownership - Tickeron.com